Notice Type
Departmental
Notice Title

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Aldara
Active Ingredient: Imiquimod 5%w/w
Dosage Form: Topical cream
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England
Product: Norditropin Simplexx
Active Ingredient: Somatropin 3.3mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Gentofte, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: Norditropin Simplexx
Active Ingredient: Somatropin 6.7mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Gentofte, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: Remicade
Active Ingredient: Infliximab 100mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Schering-Plough Animal Health Limited
Manufacturers: Parkedale Pharmaceuticals Inc, Rochester, Michigan, United States of America
Patheon Italia SpA, Stucchi, Monza, Italy
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Product: Ziagen
Active Ingredient: Abacavir sulphate 351mg equivalent to 300mg abacavir
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Operations UK Ltd, Priory Street, Ware, Hertfordshire, United Kingdom
Dated this 7th day of June 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).